Schedule 13D ownership disclosure
ALPINE IMMUNE SCIENCES INC
Security class unavailable · CUSIP: 02083G100
Event date: 2024-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-063883
- Form type
- SC 13D
- Filer
- ALPINE IMMUNE SCIENCES, INC.
- CIK
- CIK 1626199
- Filed
- May 21, 2024
- Reporting period
- May 18, 2024
- Description
- Schedule 13D beneficial ownership